how long can you be on a glp-1 medications study reveals effects may temporary A Guide to Weight-Loss Medications:

Our IHC studies on human and mouse islets confirmed our DART-Seq findings that liraglutide increases bihormonal insulin + glucagon + cells

In June, a European medical safety committee noted that Wegovy and Ozempic have been linked in very rare cases to the eye condition, Reuters reported, which led Novo Nordisk to update its European labels for Wegovy and Ozempic to state that semaglutide, their active ingredient, may cause NAION in up to 1 in 10,000 patients

M.AbebeK

Hence, the question is precise, not hypothetical

Whats changed

Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia